Search results
Pfizer's (PFE) New Multiple Myeloma Drug Elrexfio Gets FDA Nod
Zacks via Yahoo Finance· 9 months agoThe FDA's accelerated approval of Pfizer's (PFE) new multiple myeloma drug Elrexfio/elranatamab is...
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
Zacks via Yahoo Finance· 2 years agoPfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in...
FDA Accepts Pfizer's (PFE) Hemophilia B Gene Therapy Filing
Zacks via Yahoo Finance· 11 months agoPfizer PFE announced that its regulatory submissions in the United States and European Union (“EU”)...
Pfizer (PFE) Stock Rises on FDA Nod for Expanded Use of Padcev
Zacks via Yahoo Finance· 5 months agoPfizer’s PFE shares were up around 1.6% on Monday after the FDA approved the expanded use of Padcev,...
Pfizer's (PFE) COVID-19 Oral Treatment Gets FDA Nod in Adults
Zacks via Yahoo Finance· 12 months agoPer the FDA, Pfizer's (PFE) Paxlovid is the first oral antiviral pill approved in the United States...
Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote
Zacks via Yahoo Finance· 1 year agoFDA's Antimicrobial Drugs Advisory Committee (AMDAC) votes 16 to 1 for Pfizer's Paxlovid for the...
Pfizer (PFE), BioNTech Post Data on COVID Jab for Kids Under 5
Zacks via Yahoo Finance· 2 years agoPfizer PFE and partner BioNTech BNTX announced newly-updated data from a phase II/III study,...
Pfizer (PFE) Alopecia Drug Filings Get Accepted by FDA, EMA
Zacks via Yahoo Finance· 2 years agoPfizer PFE announced that the FDA has accepted its new drug application (NDA), seeking approval of...
FDA Expands Pfizer's (PFE) Talzenna Label in Prostate Cancer
Zacks via Yahoo Finance· 11 months agoFollowing FDA's label-expansion approval, Pfizer's (PFE) Talzenna is the first PARP inhibitor...
1 Green Flag and 1 Red Flag for Pfizer
Motley Fool· 11 months agoShares in Pfizer (NYSE: PFE) were falling recently after it discontinued clinical trials for a potential diabetes and weight-loss therapy. Pfizer has had...
